Summary
Wilson Mak is a biotech founder and CTO with 11 years of experience translating computational enzyme design into GMP-scale biomanufacturing. He built the protease platform behind Amplifye P24 and led assay, HPLC/UPLC, and DoE-optimized fed-batch processes that scaled through 45,000 L and delivered >90% purity at target COGS. Equally comfortable with Rosetta/AlphaFold-driven enzyme engineering and bench-to-production execution, he authored foundational patents and helped secure $22M+ in funding including an $18.4M Series A. He also drove regulatory strategy (Self-Affirmed GRAS), qualified global CDMOs, and developed automation microservices (Python/FastAPI/Pinecone) to streamline internal R&D workflows. Based in Sacramento, he blends deep academic rigor from a PhD with hands-on operations leadership, uniquely bridging computational discovery, analytics, and large-scale food-grade manufacturing. An unexpected strength: he pairs enzyme discovery intuition with practical automation to compress the path from sequence to compliant commercial product.
11 years of coding experience
4 years of employment as a software developer
Doctor of Philosophy (Ph.D.), Chemistry, Doctor of Philosophy (Ph.D.), Chemistry at University of California, Davis
Bachelor of Science (BS), Biochemistry, Bachelor of Science (BS), Biochemistry at Brigham Young University - Hawaii
French, English, Chinese, Chinese